{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T17:48:16Z","timestamp":1786297696084,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.msard.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T12:28:27Z","timestamp":1515241707000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients"],"prefix":"10.1016","volume":"20","author":[{"given":"E.","family":"Carnero Contentti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Soto de Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Daccach Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Antunes Barreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Armas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"de Aquino Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rubstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lavigne Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.M.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Tkachuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5\u20136","key":"10.1016\/j.msard.2018.01.001_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000448092","article-title":"Diagnostic utility of systematic aquaporin-4 antibodies determination in the first event of immune-mediated optic neuritis","volume":"76","author":"Carnero Contentti","year":"2016","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.msard.2018.01.001_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jns.2016.12.033","article-title":"Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: disease heterogeneity","volume":"373","author":"Carnero Contentti","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.msard.2018.01.001_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s13760-016-0742-y","article-title":"Etiologic spectrum and functional outcome of the acute inflammatory myelitis","volume":"117","author":"Carnero Contentti","year":"2017","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.msard.2018.01.001_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.msard.2017.11.004","article-title":"Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: a cohort of Latin American patients","volume":"19","author":"Carnero Contentti","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2018.01.001_bib5","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1212\/01.WNL.0000145762.60562.5D","article-title":"Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis","volume":"63","author":"Cree","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2018.01.001_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/1352458516663853","article-title":"The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates","volume":"23","author":"Hamid","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2018.01.001_bib7","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004611","article-title":"Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan","author":"Houzen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.01.001_bib8","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/WNL.0000000000002655","article-title":"Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder","volume":"86","author":"Hyun","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2018.01.001_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.msard.2018.01.001_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optical: a multicenter study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2018.01.001_bib11","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","article-title":"Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica","volume":"81","author":"Jiao","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.01.001_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp-2014-308984","article-title":"Overlapping CNS inflammatory diseases: differentiating features of NMO and MS","volume":"86","author":"Jurynczyk","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2018.01.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2018.01.001_bib14","doi-asserted-by":"crossref","first-page":"e108320","DOI":"10.1371\/journal.pone.0108320","article-title":"A longitudinal brain magnetic resonance imaging study of neuromyelitis optica spectrum disorder","volume":"26","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2018.01.001_bib15","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.msard.2018.01.001_bib16","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2018.01.001_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.msard.2018.01.001_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7224\/1537-2073.2012-048","article-title":"The incidence and prevalence of neuromyelitis optica: a systematic review","volume":"15","author":"Marrie","year":"2013","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.msard.2018.01.001_bib19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2018.01.001_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2018.01.001_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.msard.2015.06.003","article-title":"Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: a meta-analysis","volume":"4","author":"Ruiz-Gaviria","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2018.01.001_bib22","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1212\/NXI.0000000000000225","article-title":"Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus","volume":"3","author":"Sep\u00falveda","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2018.01.001_bib23","article-title":"Epidemiology of NMOSD in Catalonia: influence of the new 2015 criteria in incidence and prevalence estimates","author":"Sep\u00falveda","year":"2017","journal-title":"Mult. Scler."},{"issue":"13","key":"10.1016\/j.msard.2018.01.001_bib24","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1212\/WNL.0000000000003152","article-title":"The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study","volume":"87","author":"Solomon","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2018.01.001_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.33588\/rn.6505.2017037","article-title":"Espectro de neuromielitis \u00f3ptica: descripci\u00f3n de una cohorte seg\u00fan los criterios diagn\u00f3sticos de 2015","volume":"65","author":"Uribe-San Martin","year":"2017","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.msard.2018.01.001_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serological diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.01.001_bib27","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.01.001_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2018.01.001_bib29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/1352458516688352","article-title":"Neuromyelitis optica spectrum disorder diagnostic criteria: sensitivity and specificity are both important","volume":"23","author":"Wingerchuk","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2018.01.001_bib30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2018.01.001_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jamaneurol.2013.5055","article-title":"Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis","volume":"71","author":"Yujuan","year":"2014","journal-title":"JAMA Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818300014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818300014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:42:55Z","timestamp":1761900175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034818300014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":31,"alternative-id":["S2211034818300014"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.01.001","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}